NHSc’s HMO blend deemed effective for babies allergic to cow’s milk protein

According to research presented at the European Academy of Allergy and Clinical Immunology (EAACI) Hybrid 2021 Congress, AAF, Alfamino HMO, following the addition of Nestle’s HMO blend of 2’FL and LNnT, is safe, promotes normal growth in babies and is effective specifically for those with moderate to severe cow’s milk protein allergy (CMPA).